LPCN
Income statement / Annual
Last year (2024), Lipocine Inc.'s total revenue was $11.20 M,
a decrease of 492.80% from the previous year.
In 2024, Lipocine Inc.'s net income was $8.35 K.
See Lipocine Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$11.20 M |
-$2.85 M |
$500.00 K |
$16.14 M |
$0.00 |
$164.99 K |
$428.03 K |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$7.35 M
|
$10.18 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$3.85 M
|
-$13.03 M
|
$500.00 K
|
$16.14 M
|
$0.00
|
$164.99 K
|
$428.03 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.34
|
4.57
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
| Research and Development Expenses |
$7.31 M
|
$10.18 M
|
$8.56 M
|
$7.67 M
|
$9.75 M
|
$7.47 M
|
$6.46 M
|
$11.00 M
|
$8.08 M
|
$12.58 M
|
| General & Administrative Expenses |
$5.00 M
|
$4.90 M
|
$4.06 M
|
$5.33 M
|
$8.25 M
|
$5.60 M
|
$5.29 M
|
$10.21 M
|
$10.38 M
|
$5.80 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.00 M
|
$4.90 M
|
$4.06 M
|
$5.33 M
|
$8.25 M
|
$5.60 M
|
$5.29 M
|
$10.21 M
|
$10.38 M
|
$5.80 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$5.00 M
|
$15.08 M
|
$11.80 M
|
$16.64 M
|
$20.65 M
|
$12.83 M
|
$12.09 M
|
$20.98 M
|
$18.97 M
|
$18.38 M
|
| Cost And Expenses |
$12.35 M
|
$15.08 M
|
$11.80 M
|
$16.64 M
|
$20.65 M
|
$12.83 M
|
$12.09 M
|
$20.98 M
|
$18.97 M
|
$18.38 M
|
| Interest Income |
$1.15 M
|
$1.37 M
|
$545.48 K
|
$135.59 K
|
$310.97 K
|
$343.25 K
|
$0.00
|
$0.00
|
$0.00
|
$173.89 K
|
| Interest Expense |
$0.00
|
$0.00
|
$27.10 K
|
$203.29 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$41.11 K
|
$28.66 K
|
$9.45 K
|
$380.00
|
$3.55 K
|
$15.44 K
|
$18.60 K
|
$28.37 K
|
$31.96 K
|
$26.72 K
|
| EBITDA |
-$1.11 M |
-$17.90 M |
-$10.72 M |
-$430.53 K |
-$17.99 M |
-$12.65 M |
-$11.31 M |
-$21.19 M |
-$18.94 M |
-$18.36 M |
| EBITDA Ratio |
-0.1
|
6.28
|
-21.44
|
-0.03
|
0
|
-76.66
|
-26.42
|
0
|
0
|
0
|
| Operating Income Ratio |
-0.1
|
6.29
|
-24.24
|
0.19
|
0
|
-78.19
|
-26.46
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.16 M
|
$1.58 M
|
$1.36 M
|
-$3.78 M
|
-$2.97 M
|
-$106.85 K
|
-$333.50 K
|
$235.82 K
|
$216.08 K
|
$173.89 K
|
| Income Before Tax |
$9.03 K
|
-$16.35 M
|
-$10.76 M
|
-$634.20 K
|
-$20.96 M
|
-$13.01 M
|
-$11.66 M
|
-$20.98 M
|
-$18.97 M
|
-$18.21 M
|
| Income Before Tax Ratio |
0
|
5.74
|
-21.52
|
-0.04
|
0
|
-78.84
|
-27.24
|
0
|
0
|
0
|
| Income Tax Expense |
$681.00
|
$755.00
|
$681.00
|
$200.00
|
$200.00
|
$200.00
|
$700.00
|
$700.00
|
$752.00
|
$200.00
|
| Net Income |
$8.35 K
|
-$16.35 M
|
-$10.76 M
|
-$634.40 K
|
-$20.96 M
|
-$13.01 M
|
-$11.66 M
|
-$20.98 M
|
-$18.97 M
|
-$18.21 M
|
| Net Income Ratio |
0
|
5.74
|
-21.52
|
-0.04
|
0
|
-78.84
|
-27.24
|
0
|
0
|
0
|
| EPS |
0.0016 |
-3.14 |
-2.15 |
-0.19 |
-6.46 |
-8.54 |
-9.35 |
-17.79 |
-17.66 |
-18.79 |
| EPS Diluted |
0.0015 |
-3.14 |
-2.05 |
-0.12 |
-6.4 |
-8.54 |
-9.28 |
-17.85 |
-17.68 |
-18.87 |
| Weighted Average Shares Out |
$5.34 M
|
$5.27 M
|
$4.99 M
|
$3.30 M
|
$3.25 M
|
$1.52 M
|
$1.25 M
|
$1.18 M
|
$1.07 M
|
$964.94 K
|
| Weighted Average Shares Out Diluted |
$5.42 M
|
$5.27 M
|
$5.26 M
|
$5.15 M
|
$3.28 M
|
$1.52 M
|
$1.26 M
|
$1.18 M
|
$1.07 M
|
$968.87 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
